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The  emergence  and  increasing  prevalence  of 
bacterial strains that cause infectious diseases and that 
are  resistant  to  available  antibiotics  demand  the 
discovery  of  new  therapeutic  strategies  [1].    An 
alternative approach to antimicrobial therapy is targeting 
bacterial virulence that offers promising opportunities to 
inhibit  pathogenesis  and  its  consequences  without 
placing  immediate  life-or-death  pressure  on  the  target 
bacterium. Certain virulence factors have been shown to 
be  potential  targets  for  drug  design  and  therapeutic 
intervention,  whereas  new  insights  are  crucial  for 
exploiting others. Targeting virulence represents a new 
paradigm to empower the clinician to prevent and treat 
infectious diseases [1-3]. 
While  many  antivirulence  targets  exist,  we 
focuses  on  adhesion  as  an  antivirulence  target.  If 
adherence can be inhibited, then the subsequent infection 
can also be inhibited. This approach forms the basis of 
anti-adherence  strategies,  which  have  been  devised  to 
prevent a variety of bacterial infections [4].  
For  many  pathogenic  bacteria,  infections  are 
initiated only after the organism has first adhered to the 
host  cell  surface.  Pathogenic  bacteria  must  stably 
colonize  mucosal  surface  to  initiate  the  infectious 
process  [5].    Bacteria  attach  to  their  appropriate 
environmental  niche  by  using  adhesins.  To  maximize 
their  contact  with  the  environment,  adhesins  are  often 
present on the ends of long hair-like structures called pili 
[6].  Adhesion  to  tissue  surface  realizes  by  specific 
interactions between molecules of recognition (receptors) 
on host cell surface and adhesive molecules (adhesins) 
on the surfaces of the bacteria [5]. 
With  anti-adhesion  therapies  for  bacterial 
infections bacteria are not killed but are prevented from 
causing harm to a host by inhibiting adherence to host 
cells and tissues [7].   There are some modern strategies 
for  anti-adhesion  therapy.  For  example,  bacterial 
attachment can be inhibited by interfering with adhesin 
biosynthesis (1), adhesin assembly (2) or host receptor 
assembly (3). Binding can be inhibited by competitive 
replacement of the adhesin from the host (4) or of the 
host  receptor  from  the  adhesin  (5)  using  soluble 
molecules or by using designer microbes (6). Antibodies 
against  bacterial  adhesins  can  block  surface  epitopes 
required for binding (7) [8].  
So,  the  mechanisms  of  these  potential 
therapeutic  agents  include  inhibition  of  adhesins  and 
their  host  receptors,  vaccination  with  adhesins  or 
analogs, use of probiotics and dietary supplements that 
interfere with receptor-adhesin interactions, subminimal 
inhibitory concentrations of antibiotics and manipulation 
of  hydrophobic  interactions  [7].    The  validity  of  this 
approach  has  been  unequivocally  demonstrated  in 
experiments  performed  in  a  wide  variety  of  animals, 
from mice to monkeys, and recently also in humans [9].  
New  efficacy  in  vitro  assays  have  been 
developed  allowing  screening  of  large  numbers  of 
molecules.  These  inhibitors  are  mainly  antibacterial 
molecules,  a  few  natural  products,  peptides  and 
antibodies. A growing number of these published studies 
provide  results  showing  a  proof  of  concept  with 
antivirulence  compounds  that  were  able  to  prevent  or 
treat  an  infection  in  vivo.  Moreover,  some  new 
antivirulence agents could inhibit virulence mechanisms 
that are common to different related pathogenic species, 
extending  the  potential  spectrum  of  antivirulence 
compounds.  The  progress  reported  recently  for 
antivirulence molecules at the preclinical stages should 
allow  new  classes  of  molecules  to  enter  into 
development  as  new  antimicrobial  agents  with  new 
mechanisms of action [10]. 
Among  the  general  types  of  anti-adherence 
agents  the  most  well-studied  are  the  receptor  analogs, 
which include oligosaccharides produced synthetically or 
derived from natural sources, including milk, berries, and 
other plants. Their ability to inhibit pathogen adherence 
may  lead  to  development  of  novel,  food-grade  anti-
infective agents that are inexpensive and safe [4].  
Because  anti-adhesive  agents  are  not 
bactericidal,  the  propagation  and  spread  of  resistant 
strains is much less likely to occur than as a result of 
exposure to bactericidal agents, such as antibiotics. Anti-
adhesive drugs, once developed, may, therefore, serve as 
a new means to fight infectious diseases [9]. 
Another  opportunity  to  prevent  pathogen 
adherence is developing and use vaccines with adhesive 
antigens.  In  the  literature  it’s  described  studies  on  the 
possibility to use in therapy either purified adhesins or 
receptors  to  block  receptors  and  ligands  respectively, 
studies  on  the  development  of  antiadhesive  vaccines, 
composed  of  purified  ligands,  to  elicit  local  immune 
responses,  resulting  in  the  secretion  of  antibodies  that 
cover  the  bacterial  adhesins  and  thereby  prevent 
attachment  [5].  Also  they  have  reported  about  the 
development and use of antibodies or antisera directed 
against bacterial adhesins as an anti-adhesive strategy [8, 
11].  The host can be directly or passively immunized 
using a bacterial adhesin, an adhesin subunit (as in the 
case  of  multi-subunit  adhesive  organelles,  such  as 
fimbriae),  or  an  immunogenic  peptide  fragment  based 
either  on  an  individual  adhesin  or  on  the  consensus 
derived from a group of adhesins. Lastly, the host can be 
immunized using a DNA vaccine encoding the adhesin 
or part thereof [8]. 
  Subunit-based vaccines are often used in the 
context of  fimbrial adhesins  and several of them  have 
been described for therapeutic use against pathogenic E. 
coli. Enterotoxigenic E. coli (ETEC) are a major cause of 8 
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diarrheal  disease  in  humans  and  other  animals  and 
pathogenicity is to a large extent caused by enterotoxins. 
A fusion protein consisting of FaeG, the major subunit of 
E. coli K88ac fimbriae, an epitope from the B subunit of 
heat-labile (LT) toxin and the A subunit of shiga toxin 
(STa)  was  used  to  immunize  rabbits.  Data  from  this 
study demonstrated that K88ac fimbriae expressing LT 
and STa epitope antigens elicited neutralizing anti-toxin 
antibodies and anti-adhesin antibodies and suggested that 
E.  coli  fimbriae  could  serve  as  a  platform  for  the 
development of broad-spectrum vaccines against ETEC. 
Anti-K88ac,  anti-LT  and  anti-STa  antibodies  inhibited 
adhesion  of  fimbrial  E.  coli  to  small  intestinal 
enterocytes and neutralized both shiga toxin and cholera 
toxin [8, 12]. 
A  similar  strategy  was  pursued  to  generate 
antibodies  against  enterohemorrhagic  E.  coli  (EHEC). 
EHEC attachment to the host is primarily due to intimin 
and the subsequent pathology is caused by shiga toxin. A  
SSI (Statens Serum Institute) fusion protein containing 
two different toxin antigens as well as an intimin antigen 
fragment,  was  used  to  immunize  mice.  The  fusion 
protein induced a strong humoral immune response, with 
both  toxin  neutralizing  and  anti-adhesion  antibodies 
being  generated.  Subsequent  bacterial  challenge  of 
twice-immunized mice with an otherwise lethal dose of 
EHEC strain O157:H7 did not cause any pathology [8, 
13]. SSI protein provides evident protection  with two-
time immunization against a highly lethal dose of E. coli 
O157:H7. 
The use of preventive vaccines against recurring 
urinary tract infections (UTIs) based on fimbrial subunits 
FimCH has been investigated quite extensively both in 
animal  models  and  clinical  trials.  Immunization  with 
candidate FimH vaccines reduced in vivo colonization of 
the  bladder  mucosa  by  more  than  99  %  in  a  murine 
model [8, 11, 14].  
A major focus in the development of vaccines 
and in antibody-based therapeutic strategies is inhibiting 
antibodies targeting receptor-binding pockets in proteins. 
By using a common mannose-specific fimbrial adhesin 
of Escherichia coli, FimH, it’s demonstrated that locking 
the adhesin in a low-binding conformation induces the 
production  of  binding  pocket-specific,  adhesion-
inhibiting  antibodies  [11].  A  di-sulfide  bridge  was 
introduced  into  the  conformationally  dynamic  FimH 
lectin domain, away  from the  mannose-binding pocket 
but  rendering  it  defective  with  regard  to  mannose 
binding.  Unlike  the  native,  functionally  active  lectin 
domain, the functionally defective domain was potent in 
inducing inhibitory monoclonal antibodies that blocked 
FimH-mediated bacterial adhesion to epithelial cells and 
urinary bladder infection in mice. Inhibition of adhesion 
involved direct competition between the antibodies and 
mannose for the binding pocket. Binding pocket-specific 
inhibitory  antibodies  also  were  abundant  in  polyclonal 
immune serum raised against the functionally defective 
lectin  domain.  The  monoclonal  antibodies  elicited 
against the binding-defective protein bound to the high-
affinity conformation of the adhesin more avidly than to 
the low-affinity  form. However, both  soluble  mannose 
and  blood  plasma  more  strongly  inhibited  antibody 
recognition of the high-affinity FimH conformation than 
the low-affinity form. Authors hypothesized that in the 
functionally  active  conformation  the  binding-pocket 
epitopes  are  shielded  from  targeted  antibody 
development  by  ligand  masking  and  that  strong 
immunogenicity  of  the  binding  pocket  is  unblocked 
when  the  adhesive  domain  is  in  the  nonbinding 
conformation [11]. 
Immunization  of  monkeys  with  FimCH 
adhesin–chaperone  complex  in  combination  with  an 
adjuvant  elicited  a  strong  IgG  antibody  response  and 
protected  3/4  of  the  animals  against  subsequent 
uropathogenic  E. coli (UPEC) infection [8, 15]. These 
findings  suggest  that  a  vaccine  based  on  the  FimH 
adhesin  of  E.  coli  type  1  pili  may  have  utility  in 
preventing  cystitis  in  humans.  Urinary  tract  infections 
(UTIs)  are  considered  the  most  common  bacterial 
infections, especially in women [8, 16].  
The treatment for Salmonella enterica serovar 
Typhi,  the  causative  agent  of  typhoid  fever,  is 
increasingly  complicated  due  to  the  emergence  of 
multidrug resistant strains. The S. typhi adhesin T2544 is 
a  major  contributor  to  bacterial  host  interaction  and 
disease  pathogenesis  and  a  potential  target  for 
development  of  an  anti-adhesion  vaccine.  Deletion  of 
T2544 results in reduced systemic invasion and a 10-fold 
increase  in  LD50  in  a  murine  model.  T2544  is  highly 
immunogenic and elicits elevated titers of serum IgG and 
intestinal  secretory  IgA  in  immunized  mice.  T2544 
antiserum  enhances  both  the  uptake  and  clearance  of 
bacteria  by  macrophages  as  well  as  complement-
mediated  lysis.  Mice  either  immunized  with  T2544  or 
passively  immunized  with  anti-T2544  antiserum  were 
protected  against  subsequent  bacterial  challenge  and 
showed increased bacterial shedding [8, 15]. However, 
T2455-based  immunization  did  not  completely  inhibit 
disease  and  this  is  likely  due  to  other  structures 
promoting cellular invasion, such as type IV pili [8, 17-
19]. 
With S. typhimurium, the effect of multifactorial 
adhesion  on  the  outcome  of  immunization  attempts  is 
equally  problematic.  SadA,  a  purported  trimeric 
autotransporter  adhesin  of  Salmonella  enterica  serovar 
Typhimurium  involved  in  cell  aggregation,  biofilm 
formation,  autoaggregation  and  host  binding  by  S. 
typhimurium,  was  tested  as  a  vaccine  candidate. 
Expression  of  SadA  resulted  in  increased  adhesion  to 
human  intestinal  Caco-2  epithelial  cells.  Although 
purified  SadA  itself  triggered  an  immune  response, 
which  was  even  more  pronounced  when  administered 
together  with  an  adjuvant,  it  provided  only  limited 
protection against subsequent bacterial challenge [8, 20]. 
As it’s turned out it’s not a dominant, protective antigen 
for antibody-mediated protection against Salmonella. 
A  cheap  and  efficient  way  to  achieve  the 
necessary  multivalency  of  inhibitive  epitopes  is  their 
heterologous  expression  on  the  surface  of  probiotic 
bacteria.  The  protective  effects  of  probiotic  bacteria 
against  infections  has  long  been  appreciated,  and  has 
been systematically demonstrated in a range of trials [8].  9 
Annals of Mechnikov Institute, N 2, 2014  
www.imiamn.org.ua /journal.htm 
 
 
Probiotic strains have also been used to reduce pathogen 
colonization of animals raised for human consumption. 
For example, treatment of broiler chicken with a multi-
species probiotic consisting of bacteria isolated from the 
chicken  gut  prevented  their  colonization  by 
Campylobacter  jejuni.  The  beneficial  effects  of 
probiotics  are,  to  some  extent,  due  to  competitive 
exclusion of pathogenic bacteria from host binding sites 
although  this  is  challenging  to  demonstrate  in  vivo 
because of the complexity of the probiotics’ mechanisms 
of  action.  Over  recent  years,  probiotics  have  been 
specifically  engineered  to  mimic  sugars  on  host 
receptors,  thereby  blocking  the  host  cell  binding  of 
toxins released by pathogenic bacteria including ETEC, 
shiga toxin-producing E. coli (STEC) and V. cholerae. 
[8, 12].   
  Pseudomonas aeruginosa  and  Pseudomonas 
maltophilia account for 80 % of opportunistic infections 
by  pseudomonads.  Pseudomonas  aeruginosa  is  an 
opportunistic  pathogen  that  causes  urinary  tract 
infections, respiratory system infections, dermatitis, soft 
tissue infections, bacteremia, and a variety of systemic 
infections, particularly in patients with severe burns, and 
in cancer and AIDS patients who are immunosuppressed. 
Pseudomonas aeruginosa is notable for its resistance to 
antibiotics,  and  is  therefore  a  particularly  dangerous 
pathogen.  The  identification  and  isolation  of  a  small 
peptide structural element found in P. aeruginosa strain 
K  (PAK)  bacterial  pili,  which  has  been  proven  to 
function as a host epithelial cell-surface receptor binding 
domain were described in the study [8, 21]. Several of 
heterologous peptide founded in the pili of all strains of 
P.  aeruginosa  sequences  have  been  used  in  the 
development  of  an  consensus  sequence  anti-adhesin 
vaccine targeted at the prevention of host cell attachment 
and further for the generation of a monoclonal antibody 
capable  of  prevention  and  treatment  of  existing 
infections [8, 21]. 
Another study utilizing P. aeruginosa strain K 
pili as an immunogenic target described the generation of 
monoclonal antibodies which were also cross-protective 
against P. aeruginosa strain O (PAO) and P. aeruginosa 
strain K (PAK) when used for active immunization in a 
murine model. The authors noted that the generation of 
an  effective  antibody  relied  on  the  appropriate 
presentation  of  the  immunogenic  peptide,  which  was 
achieved  through  conformational  restriction  of  the 
peptide by both C- and N-terminal coupling to a carrier 
[8, 22]. 
To improve surface display of bacterial antigens 
and trigger both humoral and cellular immune responses, 
several approaches have been taken to ensure the epitope 
is  displayed  in  a  physiological  conformation.  For 
example,  this  can  be  achieved  by  associating  adhesin 
antigens with outer membrane vesicles and this strategy 
was  used  to  create  vaccines  against  Neisseria 
meningitides,  a  causative  agent  of  meningitis  and 
septicemia [8, 23-25]. 
Acellular pertussis vaccines can be called as one 
of the modern examples of use of adhesins in immuno-
prophylactic  preparations  [26-30,  31-37].  The  main 
component  of  many  pertussis  acellular  vaccines  is 
pertussis  toxoid.  But  if  the  vaccine  contains  only 
pertussis toxoid, it prevents only severe pertussis which 
accompanies with spasmodic cough with a period of over 
3 weeks. To prevent mild forms of the disease which is 
particularly  important  for  the  family  members  of  the 
patient, as well as during epidemics adhesins (pertactin, 
fimbriae)  and  filamentous  hemagglutinin  should  be 
included in the vaccine. 
Pertactin is an outer membrane protein with a 
molecular  weight  of  69  000  kDa.  It’s  a  factor  that 
mediates  the  close  relationship  between  the  bacterium 
Bordetella  pertussis  and  macroorganism  cells. 
Filamentous hemagglutinin  (FHA) is an another  factor 
that mediates that relationship and the second component 
of  many  pertussis  acellular  vaccines.  Rod-shaped 
molecules  of  this  surface  protein  have  a  molecular 
weight  of  220  000  kDa.  There  are  an  incorporated  
repeating  sequence  arginine-glycine-aspartic  acid  in 
pertactin  and  filamentous  hemagglutinin,  which  makes 
them  similar  to  integrins  belonging  to  a  family  of 
adhesion  molecules  in  mammals.  Antibodies  are 
produced  by  first  administering  of  the  FHA  antigen, 
prevent adhesion pertussis pathogen, however, if it does 
occurs,  the  main  component  antibody  neutralizes 
pertussis toxin which defines clinical symptoms of the 
disease generally. 
The  next  colonization  factor  antigens  of 
B.pertussis  are  fimbriae  (pili).  They  are  threadlike 
protein organelles that penetrate the outer membrane and 
cover  the  entire  surface  of  the  pertussis  bacterial  cell. 
The  separate  cells  may  have  several  hundred  fimbriae 
that  perform  different  functions.  It’s  believed  that 
ensuring fixing of bacteria in tissues is the main function 
of  pili.  Pili  are  composed  of  a  plurality  of  identical 
protein subunits. This subunit called pilin, its molecular 
weight is from 17 000 to 30 000 kDa. Conserved and 
variable  regions  are  included  in  pilin.  Chromosome 
rearrangements leading to the expression of any of the 
plurality of inactive pilin genes, accompanied by changes 
in the antigenic composition of pili [26-30, 31-37]. 
Antigens can be displayed on the surface of live, 
attenuated  bacterial  strains  which  can  be  used  as  oral 
vaccines  [8,  12,  14,  38].  A  recent  clinical  study  of 
sublingual bacterial vaccine Uromune® which contained 
an inactivated bacterial cell suspension of selected strains 
of  Escherichia  coli,  Klebsiella  pneumoniae,  Proteus 
vulgaris,  and  Enterococcus  faecalis  comparing  the 
efficacy  of  preventive  vaccination  to  prophylactic 
treatment with antibiotics concluded that vaccination was 
a more effective strategy to reduce frequency, duration 
and severity of recurring UTIs [8, 12]. 
This is a low cost approach and thus particularly 
suitable for the prevention of zoonotic infectious diseases 
as it could be used to immunize large herds of animals. 
For  example,  a  live  attenuated  S.typhimurium  strain 
expressing  a  combination  of  E.  coli  fimbrial  antigens 
(K88ab,  K88ac,  FedA,  and  FedF)  prevented  post-
weaning  diarrhea  in  piglets  when  used  to  immunize 
pregnant  pigs  [38].  No  environmental  exposure  was 
reported because no live bacteria from the vaccine strain 10 
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were shed by the animals following immunization [8, 38, 
39]. 
Vaccination with recombinant adhesins from the 
RgpA-Kgp proteinase-adhesin complex protects against 
Porphyromonas  gingivalis  infection.  All  of  the 
recombinant adhesin domains were found to significantly 
attenuate  P.  gingivalis  infection  [40-42].  The  P. 
gingivalis  cell  surface  RgpA-Kgp  proteinase-adhesin 
complex and synthetic ABM (potential adhesin binding 
motifs) and proteinase active site peptides conjugated to 
diphtheria  toxoid,  when  used  as  vaccines,  protected 
against P. gingivalis-induced periodontal bone loss in the 
murine  periodontitis  model.  The  results  suggest  that 
when  the  RgpA-Kgp  complex,  or  functional  binding 
motif or active site peptides are used as a vaccine, they 
induce a Th2 response that blocks function of the RgpA-
Kgp complex and protects against periodontal bone loss 
[42]. The recombinant A1 adhesin therefore has potential 
in the development of a P. gingivalis vaccine [41, 42]. 
Тhe  Triton-wt  complex  induced  a  stronger  antibody 
response  to  the  A1  adhesins  and  tended  to  be  more 
effective  in  providing  protection  in  the  mouse  lesion 
model compared with the sonication-wt complex [42]. 
DNA  vaccines  contain  DNA  encoding 
pathogen-derived antigens, which upon their expression 
in  the  host  are  able  to  elicit  protective  immunity. 
Theoretically,  this  strategy  is  advantageous  because  it 
improves  antigen  processing  and  presentation  and 
induces both humoral and cellular immune responses [8, 
43-46]. DNA vaccines have been generated and tested as 
a  tool  to  prevent  S.  aureus  infections.  Treatment  of 
staphylococcal  infections  becomes  increasingly 
complicated  by  the  high  level  of  multidrug  resistance 
seen with S. aureus. S. aureus binding to host cells is 
mediated  by  a  number  of  surface  proteins  binding  to 
extracellular  matrix  components  with  extremely  high 
affinity.  A  DNA  vaccine  based  on  collagen-binding 
protein (CNA), a major S. aureus adhesin, was used to 
immunize Balb/c mice. Mice injected with three doses of 
the eukaryotic expression vector pCNA, expressing the 
collagen-binding domain of CNA, showed evidence of 
both  antibody-  and  cell-mediated  immune  response 
against  CNA.  Even  though  the  antibodies  recognized 
intact bacteria and inhibited binding to collagen in vitro, 
they  failed  to  protect  mice  against  intra-peritoneal 
infection  by  S.  aureus  [8,  45].  A  polyprotein  DNA 
vaccine  against  S.  aureus,  consisting  of  a  series  of 
plasmids  expressing  clumping  factor  A  (ClfA), 
fibronectin binding protein A (FnBPA), and the enzyme 
sortase (Srt), triggered both antibody production and T-
cell response and provided partial protection against S. 
aureus isolate Sa042 and full protection against reactive 
arthritis after challenge with S. aureus strain Newman [8, 
47]. 
One  of  the  major  drawbacks  of  anti-adhesion 
therapy  is  the  high  degree  of  redundancy  in  bacterial 
adhesive  strategies  that  in  many  cases  interfere  with 
effective treatment. The use of anti-adhesion antibodies 
or  vaccines  may  still  be  effective  in  such  cases  as 
antibody opsonization can increase bacterial uptake and 
clearance  by  macrophages  and  antibodies  may  trigger 
complement-mediated  bacteriolysis,  even  if  they  are 
unable to fully inhibit bacterial adhesion [15]. Although 
one  could  argue  that  antigenic  variability  of  bacterial 
adhesins  can  potentially  impair  the  efficacy  of  anti-
adhesion antibodies, the fact is that many adhesins show 
a remarkable degree of conservation, making them good 
vaccine candidates [8, 9, 48].  
An intensive field of investigation and pinpoints 
the areas that need further study are pili [49]. Bacterial 
pili  are  defined  as  non-flagellar,  proteinaceous,  multi-
subunit surface appendages involved in adhesion to other 
bacteria,  host  cells,  or  environmental  surfaces  [50-52]. 
Pili  were  first  recognized  by  electron  microscopy  on 
Gram-negative bacteria more than 50 years ago [50, 53] 
and on Gram-positive bacteria more than 40 years ago  
[50, 54].  
Bacterial  pili  have  long  been  recognized  as 
mediators of initial host-pathogen interactions important 
for the progression of Gram-negative bacterial diseases 
[55]. Pili of Gram-negative pathogens are formed from 
pilin  precursor  molecules  by  non-covalent  association 
within the outer membrane envelope [56]. It’s reported 
about two strategies of drug development involved the 
inhibition of bacterial binding to the host tissue by the 
addition  of  exogenous  sugars,  and  the  disruption  of 
chaperone-usher  (CU)  pilus  assembly  through  the 
disruption of protein-protein interactions. They used pili 
of uropathogenic E. coli as a model system and believed 
that  because  of  the  commonality  of  adhesion  to 
infectious  disease  processes  and  CU  pili  to  many 
pathogens,  the  two  strategies  are  translatable  to  a 
multitude of organisms [1].  
  The chaperone-usher (CU) pathway of pilus 
biogenesis is the most widespread of the five pathways 
that  assemble  adhesive  pili  at  the  surface  of  Gram-
negative  bacteria.  Recent  progress  in  the  study  of  the 
structural biology of the CU pathway has unravelled the 
molecular basis of chaperone function and elucidated the 
mechanisms  of  fibre  assembly  at  the  outer  membrane, 
leading to a comprehensive description of each step in 
the biogenesis pathway. Other studies have provided the 
molecular  basis  of  host  recognition  by  CU  pili.  The 
knowledge  that  has  been  gathered  about  both  the 
assembly of and host recognition by CU pili has been 
harnessed  to  design  promising  antibiotic  compounds 
[57]. 
Recently, attention has focused on pili of Gram-
positive bacteria because they may be vaccine candidates 
in  important  human  pathogens.  Pili  are  highly 
immunogenic  structures  that  are  under  the  selective 
pressure of host immune responses [49]. Pili of Gram-
positive bacteria have not been extensively investigated 
yet  [6].  Since  the  beginning  of  their  study  time  it’s 
ascertained that cell surface pili in gram-positive bacteria 
have  been  implicated  in  critical  host-pathogen 
interactions,  in  adhesion  to  host  extracellular  matrix 
proteins,  colonization  of  host  tissues,  tissue  tropism 
determination, biofilm formation as one of mechanisms 
of  persistence  in  human  organism,  signaling  events, 
modulation  of  innate  immune  responses  and  their 
contribution  to  virulence,  and  the  regulation  of  their 11 
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expression,  a  characteristic  life-style  of  the  bacteria 
constituting  the  oral  flora  and  so  on    [49,  50,  58-65]. 
Gram-positive  pathogens  use  a  variety  of  surface 
proteins  as  a  key  virulence  factors  of  most  bacterial 
pathogens to bind to host tissues, evade the innate and 
acquired immune systems, and invade host epithelial and 
immune cells [58-60]. Gram-positive  microbes employ 
the cell wall peptidoglycan as a surface organelle for the 
covalent attachment of proteins [56]. 
In  the  last  decade,  pili,  which  are  encoded 
within pathogenicity islands, have been found in many 
Gram-positive  bacteria,  including  the  major 
streptococcal  and  enterococcal  pathogens.  These  long 
proteinaceous  polymers  extending  from  the  bacterial 
surface  are  constituted  of  covalently  linked  pilin 
subunits,  which play  major roles in adhesion and host 
colonization [49]. 
  Indeed,  pilus  expression  was  found  to  be 
heterogeneous in several bacteria with the co-existence 
of two subpopulations expressing various levels of pili. 
The  molecular  mechanisms  underlying  this  complex 
regulation  are  poorly  characterized  except  for 
Streptococcus pneumonia [49].  
Gram-positive  microbes  employ  the  cell  wall 
peptidoglycan  as  a  surface  organelle  for  the  covalent 
attachment of proteins, however, an assembly pathway 
for pili has not yet been revealed [56]. An appreciation of 
the  role  of  pili  on  virulence  in  Gram-positive  bacteria 
and the unique properties of their biogenesis is a rapidly 
emerging area of research [55]. 
These  pili  differ  from  the  well-studied  pili  of 
Gram-negative  bacteria  because  their  subunits  are 
covalently  linked,  they  do  not  require  specific 
chaperones for assembly, and the tip protein (likely to be 
the adhesin) is not required to initiate formation of the 
pilus structure. In Gram-positive bacteria, the genes for 
pili  occur  in  clusters,  which  may  constitute  mobile 
genetic  elements.  These  clusters  include  the 
transpeptidase(s) of the sortase family that is/are required 
for  polymerization  of  the  subunit  proteins.  However, 
efficient  covalent  attachment  of  the  completed  pilus 
structure to the cell wall is accomplished, in cases where 
this  has  been  studied,  by  the  'housekeeping'  sortase, 
which is responsible for attachment to the peptidoglycan 
of  most  surface  proteins  containing  cell  wall  sorting 
signals.  This  enzyme  is  encoded  elsewhere  on  the 
genome [6].  
  We’ll  dwell  on  adherence  factors  of 
Corynebacteria  as  probable  components  of  developing 
diphtheria  vaccines.  Pathogenic  members  of  the  genus 
Corynebacterium  cause  a  wide  range  of  serious 
infections in humans including diphtheria. The epidemic 
re-emergence  of  diphtheria  in  Russia  and  the  Newly 
Independent States of the former Soviet Union in the last 
decade of the past century demonstrated the continued 
threat of this thought to be rare disease  [60]. Diphtheria 
epidemic  in  countries  of  Eastern  Europe  in  the  1990s 
testifies  preservation  of  the  reservoir  of  infection  in 
modern  society  [60,  66-69].  Corynebacterium 
diphtheriae still represents a global  medical challenge, 
particularly due to the significant number of individuals 
susceptible  to  diphtheria  and  the  emergence  of  non-
toxigenic  strains  as  the  causative  agents  of  invasive 
infections [61, 70].  
A main virulence factor of C. diphtheriae is the 
bacteriophage encoded toxin, however, an analysis of the 
first  complete  genome  sequence  of  C.  diphtheriae 
revealed  a  recent  acquisition  of  other  pathogenicity 
factors  including  iron-uptake  systems,  adhesins  and 
fimbrial  proteins  as  indeed  this  extracellular  pathogen 
has more possibilities for lateral gene transfer than, e.g., 
its  close  relative,  mainly  intracellular  Mycobacterium 
tuberculosis.  C.  diphtheriae  appears  to  have  a 
phylogeographical structure mainly represented by area-
specific  variants  whose  circulation  is  under  strong 
influence of human host factors, including health control 
measures, first of all, vaccination, and social economic 
conditions.  This  framework  core  population  structure 
may be challenged by importation of the endemic and 
eventually toxigenic strains from new areas thus leading 
to  localized  or  large  epidemics  caused  directly  by 
imported  strains  or  by  bacteriophage-lysogenized 
indigenous  strains  converted  into  toxin  production.  A 
feature of C. diphtheriae co-existence with humans is its 
periodicity: following large epidemic in the 1990s, the 
present period is marked by increasing heterogeneity of 
the circulating populations whereas re-emergence of new 
toxigenic  variants  along  with  persistent  circulation  of 
invasive non-toxigenic strains appear alarming  [60].  
The characterized strains C. diphtheriae on the 
basis  of  the  chosen  criteria  namely  adhesive,  invasive 
and cytotoxic activity could be subdivided into highly, 
moderately  and  low  virulent  and  the  degree  of  their 
potential  epidemic  danger  could  be  determined  [71]. 
Among  non-toxigenic  strains  those  with  intermediate 
adhesiveness  were  predominated  (45,5  %)  [72].  The 
study of the main pathogenicity factors of C. diphtheriae 
(adhesive activity, toxigenicity, detection of tox+ gene) 
circulating in the Primorski Territory (Russia) has been 
revealed that at the period of declined epidemic process 
the  selection  of  C.  diphtheriae  strains  with  weak 
toxigenicity and low adhesiveness was observed  [73].  
C.  diphtheriae,  the  causative  agent  of 
diphtheria,  is  well-investigated  in  respect  to  toxin 
production,  while  little  is  known  about  C.  diphtheriae 
factors  crucial  for  colonization  of  the  host  [74].  It’s 
known that anti-toxic immunity doesn't interfere with a 
carriage of toxigenic C. diphtheria strains, their invasion 
and persistence in a human body [61, 62]. A factor which 
localizes  a  diphtheritic  infection  in  an  organism  is  an 
antibacterial  immunity.  It’s  characterized  by  cell-
mediated  immunity  and  delayed-type  hypersensitivity. 
The  carriage  is  formed  against  the  background  of  the 
reduced  antibacterial  antidiphtheritic  immunity  and 
defines  preservation  of  the  reservoir  of  infection  in 
human population [75]. Effective methods of treatment 
of  a  resistant  carrier  state  are  absent.  Experimental 
studies proved need of search of the bacterial antigenes 
responsible  for formation of organism resistance to an 
invasion of the pathogen [76]. Adhesion to host cells is a 
crucial step during infection [77].  12 
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So,  although  diphtheria  has  been  studied  to  a 
great extent, relatively little is known still about the two 
key aspects of C. diphtheriae invasiveness: colonization 
and  invasion.  The  role  of  adhesive  properties  in 
establishing  the  infection  of  C.  diphtheriae  strains, 
independent  of  toxin  production,  still  needs  to  be 
clarified  [74, 78]. It’s necessary to investigate various 
isolates on a molecular level to understand and to predict 
the  colonization  process  of  different  C.  diphtheriae 
strains   [74]. 
In  C.  diphtheriae,  adhesion  is  mediated 
primarily  by  filamentous  structures  called  pili  (or 
fimbriae) that are covalently attached to the bacterial cell 
wall [58, 59, 77]. Wild type  C. diphtheriae cells were 
shown to bind to human lung epithelial, laryngeal, and 
pharyngeal  cells  [58].  The  first  observation  that 
corynebacterial  pili  may  mediate  host  cell  interactions 
was proposed in early studies with C. renale pili, which 
were shown to agglutinate trypsinized sheep red blood 
cells  [58,  59,  79].  Using  ultrastructure  analyses  by 
atomic  force  microscopy,  significant  differences  in 
macromolecular surface structures were found between 
the  investigated  C.  diphtheriae  strains  in  respect  to 
number  and  length  of  pili    [74].  Three  distinct  pilus 
structures  can  be  produced  by  C.  diphtheriae:  SpaA-, 
SpaD-  and  SpaH-type  pili    [77,  80].  Similar  to  other 
types,  the  prototype  SpaA  pilus  consists  of  SpaA,  the 
major  pilin  protein,  forming  the  pilus  shaft  and  two 
minor pilins SpaB and SpaC located at the base and at 
the tip, respectively  [50, 56, 63, 77, 80, 81]. SpaA is 
distributed  uniformly  along  the  pilus  shaft,  whereas 
SpaB is observed at regular intervals, and SpaC seems to 
be  positioned  at  the  pilus  tip    [82].  For  the  first  time 
Mandlik et al. identified the minor pilins SpaB and SpaC 
of  C.  diphtheria  as  specific  adhesins  that  mediate 
efficient  corynebacterial  adherence  to  host  pharyngeal 
cells [58]. 
Pilus genes encode a total of nine pilus proteins, 
named SpaA through SpaI, and six sortases, named SrtA 
through SrtF, five of which are devoted to the assembly 
of three distinct types of pilus fibres – SrtA for the SpaA-
type  pilus,  SrtB/SrtC  for  the  SpaD-type  pilus,  and 
SrtD/SrtE for the SpaH-type pilus  [81]. The genome of 
C.  diphtheria  NCTC13129  contains  three  pilus  gene 
clusters, which encode for the SpaA-type pili (spaA-srtA-
spaB-spaC),  the  SpaD-type  pili  (srtB-spaD-srtC-spaE-
spaF)  and  the  SpaH-type  pili  (spaG-spaH-srtD-srtE-
spaI).  [82].  All  the  pilus  genes  are  located  on 
pathogenicity  islands  and  can  be  acquired  and  lost  by 
different strains [80].  The housekeeping sortase, srtF, is 
located elsewhere on the chromosome [82]. Similar pilus 
gene  clusters  and  the  housekeeping  sortase  gene  are 
found  in  many  pathogenic  species  of  the  genus 
Corynebacterium  [82].  
Invasiveness of C. diphtheriae strains could be 
related  to  adhesive  factors.    Most  probably  ability  to 
express  all  types  of  pili  is  indispensable  for  causing 
invasive  infections  by  nontoxigenic  C.  diphtheriae. 
Whereas full set of pili genes is not necessary for causing 
classical diphtheria  [80].  
It’s  described  a  novel  C.  diphtheriae  gene 
involved in adherence to epithelial cells. Transformation 
of  C.  diphtheriae  225,  biotype  gravis,  ribotype  St-
Petersburg  by  EZ:TN(KAN-2)Tnp  Transposome  was 
undertaken. A C. diphtheriae 225 Tn5 insertion library 
of 2800 mutants was created. Five hundred and eighty 
five  transformants  were  qualitatively  screened  for 
reduced adherence to HEp-2 cells by an adherence assay. 
One mutant strain consistently exhibiting 15.2 % of the 
wild-type adherence was isolated. The DNA flanking the 
transposon  was  identified  by  inverse  PCR  and 
subsequent  sequencing.  The  disrupted  gene  was  94 
percent identical to the C. diphtheriae DIP1621 gene that 
belongs to unclassified genes. The disruption of the C. 
diphtheriae DIP1621 gene led to decreased adherence to 
epithelial cells [78].  
Importantly, the host cell receptor(s) targeted by 
SpaB and SpaC have yet to be identified as well as the 
specific functions of the SpaD- and SpaH-type pili. Such 
studies  are  likely  to  be  rewarding  because  some 
important corynebacterial pathogens do not contain the 
SpaA-type pilus but  harbor only the SpaD-type or the 
SpaH-type pilus  [58]. 
Like pili of many other gram-positive microbes, 
the assembly of corynebacterial pili occurs by a two-step 
mechanism, whereby pilins are covalently polymerized 
by  a  transpeptidase  enzyme,  pilin-specific  sortase,  and 
the generated pilus polymer is subsequently anchored to 
the  cell  wall  peptidoglycan  via  the  base  pilin  by  the 
housekeeping sortase SrtF or a non-polymerizing sortase  
[50,  63,  77,  81].  In  C.  diphtheriae,  the  pilin-specific 
sortase SrtA catalyses polymerization of the SpaA-type 
pilus, consisting of the shaft pilin SpaA, tip pilin SpaC 
and minor pilin SpaB   [50]. 
Recent  work  revealed  that  a  multiple  deletion 
mutant  strain  expressing  only  SrtA  secretes  a  large 
portion of SpaA polymers into the culture medium, with 
concomitant  decrease  in  the  cell  wall-linked  pili.  The 
same  phenotype  is  observed  with  the  mutant  that  is 
missing SrtF alone. By contrast, a strain that expresses 
only SrtF displays surface-linked pilins but no polymers. 
Therefore, SrtF can catalyse the cell wall anchoring of 
pilin monomers as well as pili, but it does not polymerize 
pilins. SrtA and SrtF together generate wild-type levels 
of  the  SpaA-type  pilus  on  the  bacterial  surface. 
Furthermore, by regulating the expression of SpaA in the 
cell, the SrtF function becomes critical when the SpaA 
level  is  sufficiently  high.  Thus,  these  findings  provide 
key evidence for a two-stage model of pilus assembly: 
pilins are  first polymerized  by a pilus-specific sortase, 
and the resulting fibre is then attached to the cell wall by 
either  the  cognate  sortase  or  the  housekeeping  sortase 
[81].  Cell  wall  anchoring  of  the  SpaA  polymers  is 
triggered  when  SrtA  incorporates  SpaB  into  the  pilus 
base via lysine-mediated transpeptidation; anchoring to 
the cell wall peptidoglycan is subsequently catalysed by 
the housekeeping sortase SrtF [50, 63]. 
SpaB  and  SpaC  formed  a  heterodimer 
independent  of  SpaA  polymerization.  SrtA  was 
absolutely  required  for  the  formation  of  the  SpaBC 
heterodimer, while SrtF facilitated the optimal cell wall 13 
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anchoring of this heterodimer. Alanine substitution of the 
SpaB lysine residue K139 or truncation of the SpaB cell 
wall-sorting  signal  (CWSS)  abolished  assembly  of  the 
SpaBC heterodimer, hence underscoring SpaB function 
in  transpeptidation  and  cell  wall  linkage.  Importantly, 
sortase specificity for the cell wall-anchoring step was 
found to be dependent on the LAFTG motif within the 
SpaB CWSS. Thus, C. diphtheriae employs a common 
sortase-catalysed  mechanism  involving  lysine-mediated 
transpeptidation  to  generate  both  adhesive  pilus  and 
simple heterodimeric structures on the bacterial cell wall  
[50]. 
Cells lacking SpaB form pilus fibers, but they 
are  largely  secreted  in  the  medium,  a  phenotype  also 
observed  when  cells  lack  the  housekeeping  sortase. 
Furthermore, the average pilus length is greatly increased 
in the absence of SpaB. Remarkably, a SpaB mutant that 
lacks the cell wall sorting signal but contains a critical 
lysine residue is incorporated in the pilus. However, the 
resulting pili fail to anchor to the cell wall. Probably a 
specific minor pilin acts as the terminal subunit in pilus 
assembly.  Cell  wall  anchoring  ensues  when  the  pilus 
polymer  assembled  on  the  pilus-specific  sortase  is 
transferred  to  the  minor  pilin  presented  by  the 
housekeeping  sortase  via  lysine-mediated 
transpeptidation   [63]. The minor pilins SpaB/SpaC are 
critical for bacterial binding to human pharyngeal cells, 
and thus represent the major adhesins of corynebacteria 
[77]. 
  Besides  that  as  it’s  reported  mutants  that 
lacked SrtA (and thus did not polymerize SpaA-type pili) 
showed over a 90 % reduction in the ability to adhere to 
human  pharyngeal  cells.  Surprisingly,  mutants  that 
lacked  only  the  major  pilin  subunit,  SpaA,  showed  a 
modest 10 % reduction in adherence to these cells. This 
is in contrast to mutants that lacked either of the minor 
pilin subunits, SpaB or SpaC, which showed a 70–75 % 
reduction in adherence. Additionally, latex beads coated 
with only SpaB or SpaC were sufficient to adhere to host 
pharyngeal cells, while beads coated with SpaA showed 
no binding. As mentioned above, SpaB and SpaC anchor 
to  the  cell  wall  as  monomers  independent  of  pilus 
structures.  It  is  speculated  that  the  long  pili  mediate 
initial  attachment,  whereas  monomeric  pilins  on  the 
bacterial surface may help to create an intimate zone of 
adhesion that allows for efficient delivery of toxin and 
other virulence factors, and may even play a significant 
role in host cell signaling  [77, 58]. 
Assembled pili are released from the bacterial 
surface  by  treatment  with  murein  hydrolase.  All  three 
pilin  subunit  proteins  are  synthesized  as  precursors 
carrying  N-terminal  signal  peptides  and  C-terminal 
sorting signals. Some, but not all, of the six sortase genes 
encoded in the genome of C. diphtheriae are required for 
precursor  processing,  pilus  assembly  or  cell  wall 
envelope  attachment    [56].  Pilus  assembly  in  C. 
diphtheriae requires the pilin motif and the C-terminal 
sorting signal of SpaA, and is proposed to occur by a 
mechanism  of  ordered  cross-linking,  whereby  pilin-
specific  sortase  enzymes  cleave  precursor  proteins  at 
sorting signals and involve the side-chain amino groups 
of  pilin  motif  sequences  to  generate  covalent  linkages 
between  pilin  subunits.  This  covalent  tethering  of 
adjacent pilin subunits appears to have evolved in many 
Gram-positive  pathogens  that  encode  sortase  and  pilin 
subunit genes with sorting signals and pilin motifs  [56, 
82].  
Two elements of SpaA pilin precursor, the pilin 
motif  and  the  sorting  signal,  are  together  sufficient  to 
promote  the  polymerization  of  an  otherwise  secreted 
protein by a process requiring the function of the sortase 
A gene (srtA). Five other sortase genes are dispensable 
for SpaA pilus assembly. Further, the incorporation of 
SpaB  into  SpaA  pili  requires  a  glutamic  acid  residue 
within the E box motif of SpaA, a feature that is found to 
be  conserved  in  other  Gram-positive  pathogens  that 
encode  sortase  and  pilin  subunit  genes  with  sorting 
signals and pilin motifs. When the main fimbrial subunit 
of  Actinomyces  naeslundii  type  I  fimbriae,  FimA,  is 
expressed  in  corynebacteria,  C.  diphtheriae  strain 
NCTC13129  polymerized  FimA  to  form  short  fibres. 
Although  C.  diphtheriae  does  not  depend  on  other 
actinomycetal  genes  for  FimA  polymerization,  this 
process involves the pilin motif and the sorting signal of 
FimA as well as corynebacterial sortase D (SrtD). Thus, 
pilus assembly in Gram-positive bacteria seems to occur 
by  a  universal  mechanism  of  ordered  cross-linking  of 
precursor  proteins,  the  multiple  conserved  features  of 
which are recognized by designated sortase enzymes [56, 
82].  
Many  studies  have  examined  specific  surface 
components of C. diphtheriae that may be involved in 
adhesion  [58].  Among  of  them  is  a  lipoglycan  called 
CdiLAM. The key structural features of CdiLAM are a 
linear alpha-1-->6-mannan with side chains containing 2-
linked  alpha-D-Manp  and  4-linked  alpha-D-Araf 
residues.  (LAM  –  lipoarabinomanan).  The 
polysaccharide  backbone  is  linked  to  a 
phosphatidylinositol  anchor.  Unlike  the  non-fimbrial 
adhesin  62-72p,  CdiLAM  did  not  function  as  a 
hemagglutinin  to  human  red  blood  cells.  Experimental 
evidences  pointed  to  CdiLAM  as  an  adhesin  of  C. 
diphtheriae  to  human  respiratory  epithelial  cells. 
Preincubation  of  bacteria  with  anti-CdiLAM 
significantly inhibited adherence to HEp-2 cells [58, 83].  
  Another one identified in C. diphtheriae is a 
cell surface protein, DIP1281. Mutants lacking DIP1281 
show  over  3-fold  reduction  in  adherence  to  human 
pharyngeal  cells  compared  to  their  isogenic  parental 
strains [58]. Importantly, the DIP1281 mutant was also 
defective in invasion. 
  Subinhibitory  concentrations  (subMICs)  of 
antibiotics  may  alter  bacterial  surface  properties  and 
change  microbial  physiology.  Adherence  to  human 
erythrocytes was reduced after growth in the presence of 
erythromycin. All strains enhanced biofilm formation on 
glass  after  treatment  with  erythromycin.  Antibiotic-
induced  biofilm  formation  may  contribute  to  the 
inconsistent  success  of  antimicrobial  therapy  for  C. 
diphtheriae infections [84]. It has been established that 
only erythromycin in minimum inhibiting concentration 
manifested the ability to inhibit the adhesion of different 14 
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biovars  of  C.  diphtheriae.  The  drug  action  did  not 
depend  on  the  level  of  adhesive  activity  of  certain 
cultures [85]. 
  As  ascertained  adhesion  and  pili  formation 
are  not  coupled  processes  and  also  no  correlation 
between  invasion  and  pili  formation  was  found  in 
different  C.  diphtheriae  strains,  that  is  adhesion  to 
epithelial cells and invasion of these cells are not strictly 
coupled  processes.  Using  RNA  hybridization  and 
Western  blotting  experiments,  strain-specific  pili 
expression patterns were observed. None of the studied 
C. diphtheriae strains had a dramatic detrimental effect 
on host cell  viability as indicated by  measurements of 
transepithelial resistance of Detroit 562 cell monolayers 
and fluorescence microscopy, leading to the assumption 
that C. diphtheriae strains might use epithelial cells as an 
environmental  niche  supplying  protection  against 
antibodies and macrophages  [74]. 
It is obvious that antitoxic immunity does not 
prevent  carriage  of  C.  diphtheria,  its  colonization  of 
mucous membrane and stay in the human body. Lack of 
effective  treatments  for  toxigenic  Corynebacterium 
carriers, especially long-term, results in the preservation 
of the reservoir of diphtheriae infection among human 
population.  Investigation  of  pili  of  Gram-positive 
bacteria  is  the  area  most  in  need  of  further  study. 
Development  of  a  new  class  of  combined  diphtheria 
candidate vaccines with an anti-adhesion action can be 
an effective means of the limiting of mucous membranes 
colonization processes and reduce the circulation of C. 
diphtheria among population.  
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ANTI-ADHESIVE THERAPIES AS A 
CONTEMPORARY MEANS TO FIGHT 
INFECTIOUS DISEASES AND ADHERENCE 
FACTORS OF CORYNEBACTERIA 
DIPHTHERIAE 
Yelyseyeva I. V., Babych Ye. M., Zhdamarova L. A.,  
Belozersky V. I., Isayenko Ye. Yu., Kolpak S. A. 
The emergence and increasing prevalence of bacterial 
strains that cause infectious diseases and that are 
resistant to available antibiotics demand the discovery of 
new therapeutic strategies. For many pathogenic 
bacteria, infections are initiated only after the organism 
has first adhered to the host cell surface. A modern 
alternative approach to antimicrobial therapy is targeting 
bacterial virulence and specifically adhesion as one of 
virulence factors. This approach forms the basis of anti-
adherence strategies, which have been devised to prevent 
a variety of bacterial infections. The article deals with 
some modern strategies for anti-adhesion therapy, the 
mechanisms of inhibition pathogen adherence,  
immunization using a bacterial adhesion, an adhesin 
subunit  or an immunogenic peptide fragment and a 
DNA vaccine encoding the adhesin or part thereof and so 
on. Investigation of bacterial pili which orchestrate the 
colonization of host tissues is the area most in need of 
further study. Bacterial pili may be vaccine candidates in 
important human pathogens as being highly 
immunogenic structures which are under the selective 
pressure of host immune responses. C. diphtheriae, the 
causative agent of diphtheria, is well-investigated in 
respect to toxin production, while little is known about 
its factors crucial for colonization of the host.   
Adherence factors of Corynebacteria may be considered 
as probable components of developing of combined 
diphtheria vaccines with antibacterial action which 
localizes a diphtheritic infection in an organism. They’ll 
become an effective  method against a resistant carrier 
state and be forward to stopping of pathogen circulation 
among human population.   
Key words: adhesion, pili, C. diphtheriaе, anti-adhesion 
therapy, antibacterial immunity, diphtheria vaccines 
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АНТИАДГЕЗИВНА ТЕРАПІЯ ЯК СУЧАСНИЙ 
ЗАСІБ БОРОТЬБИ З ІНФЕКЦІЙНИМИ 
ХВОРОБАМИ ТА АДГЕЗИВНІ ФАКТОРИ 
КОРИНЕБАКТЕРІЙ ДИФТЕРІЇ 
Єлисеєва І. В., Бабич Є. М., Ждамарова Л. А., 
Білозерський В. І., Ісаєнко О. Ю., Колпак С. А. 
Виникнення і розповсюдження бактеріальних 
штамів, котрі викликають інфекційні захворювння і є 
стійкими до антибіотиків, потребують відкриття 
нових терапевтичних стратегій. Для багатьох 
патогенних бактерій інфекційний процесс 
ініціалізується лише після адгезії мікроорганізму на 19 
Annals of Mechnikov Institute, N 2, 2014  
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поверхні клітин організму хазяїна. Сучасним 
альтернативним підходом до антимікробної терапії є 
націлювання на бактерійну вірулентність  та, 
особливо, адгезію як один з факторів вірулентності. 
Цей підхід формує основу антиадгезивних напрямків 
лікування, розроблених для попередження багатьох 
бактерійних інфекцій. У статті йдеться про деякі 
сучасні стратегії антиадгезивної терапії, механізми 
пригнічення адгезії патогену, імунізацію з 
використанням бактерійних адгезинів, адгезивних 
субодиниць або фрагментів імуногенних пептидів і 
ДНК вакцин, кодуючих адгезин або його частину, і 
т.і. Дослідження бактеріальних пілей, котрі керують 
колонізацією тканин хазяїна, є областю, яка нагально 
потребує подальшего вивчення. Бактерійні пілі, котрі 
є високо імуногенними структурами, знаходяться під 
селективним тиском імунної відповіді хазяїна і 
можуть бути кандидатами у вакцини для багатьох 
важливих патогенів людини. C. diphtheriaе, збудник 
дифтерійної інфекції, добре вивчений у відношенні 
токсиноутворення, тоді як про його фактори, 
вирішальні для колонізації хазяїна, відомо мало. 
Адгезивні фактори Corynebacteria можна роглядати 
як вірогідні компоненти комбінованих дифтерійних 
вакцин з антибактерійною дією, котрі локалізують 
дифтерійну інфекцію в організмі. Вони можуть стати 
ефективним засобом проти стійкого 
бактеріоносійства і будуть сприяти припиненню 
циркуляції збудника в людській популяції.  
Ключові слова: адгезія, пілі, C. diphtheriaе, анти-
адгезивна терапія, антибактерійний імунитет, 
дифтерийні вакцины 
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АНТИАДГЕЗИВНАЯ ТЕРАПИЯ КАК 
СОВРЕМЕННЫЙ СПОСОБ БОРЬБЫ С 
ИНФЕКЦИОННЫМИ ЗАБОЛЕВАНИЯМИ И 
АДГЕЗИВНЫЕ ФАКТОРЫ КОРИНЕБАКТЕРИЙ 
ДИФТЕРИИ 
Елисеева И. В., Бабич Е. М., Ждамарова Л. А., 
Белозерский В. И., Исаенко Е. Ю., Колпак С. А. 
Возникновение и распространение бактериальных 
штаммов, которые вызывают инфекционные 
заболевания и являются устойчивыми к 
антибиотикам, требуют открытия новых 
терапевтических стратегий. Для многих патогенных 
бактерий инфекционный процесс инициализируется 
только после адгезии микроорганизма на 
поверхности клеток организма хозяина. 
Современным альтернативным подходом к 
антимикробной терапии  является нацеливание на 
бактериальную вирулентность и, особенно, адгезию 
как один из факторов вирулентности. Этот подход 
формирует основу антиадгезивных направлений 
лечения, разработанных для предупреждения 
множества бактериальных инфекций.  В статье речь 
идет о некоторых современных стратегиях 
антиадгезивной терапии, механизмах подавления 
адгезии патогена, иммунизации с использованием 
бактериальных адгезинов, адгезивных субъединиц 
или фрагментов иммуногенных пептидов и ДНК 
вакцин, кодирующих адгезин или его часть и т.д. 
Исследование бактериальных пилей, которые 
управляют колонизацией тканей хозяина, является 
областью, крайне нуждающейся в дальнейшем 
изучении. Бактериальные пили, будучи высоко 
иммуногенными структурами, находящимися под 
селективным давлением иммунного ответа хозяина, 
могут быть кандидатами в вакцины для многих 
важных патогенов человека. C. diphtheria, 
возбудитель дифтерийной инфекции, хорошо изучен 
в отношении токсинообразования, тогда как о его 
факторах, решающих для колонизации хозяина, 
известно мало. Адгезивные факторы Corynebacteria 
можно рассматривать как вероятные компоненты 
комбинированных дифтерийных вакцин с 
антибактериальным действием, которые локализуют 
дифтерийную инфекцию в организме. Они могут 
стать эффективным средством против стойкого 
бактерионосительства и будут способствовать 
прекращению циркуляции возбудителя в 
человеческой популяции. 
Ключевые слова: адгезия, пили, C. diphtheriaе, 
анти-адгезивная терапия, антибактериальный 
иммунитет, дифтерийные вакцины 